SOLV · Solventum Corporation
$79.532026-07-21Sector: Healthcare; Industry: Medical - Care Facilities; Sub-Industry: Health Care Technology
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Base · active
$115
+45.1% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($117 · $97) Analysts Range ($43 · $100) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $8.2B | — | 21.9% | 21.0% | $1.4B | $226MM | $1.6B | 7.2% | — | 10.5% | $13.5B | $7.67 | — |
| 2024.Q4 | $8.2B | 0.0% | 21.9% | 21.0% | $1.4B | $206MM | $1.6B | 6.9% | — | 10.9% | $12.5B | $7.67 | — |
| 2025.Q1 | $8.3B | 0.7% | 13.3% | 0.0% | $1.3B | −$49MM | $1.3B | 8.9% | — | 10.3% | $13.0B | $2.73 | — |
| 2025.Q4 | $8.3B | 0.0% | 13.3% | 9.2% | $997MM | $3.5B | $4.5B | 6.8% | — | 8.1% | $11.6B | $2.73 | — |
| 2026.Q1 | $8.3B | 0.1% | 27.1% | 15.3% | $1.9B | −$982MM | $911MM | 7.6% | — | 16.2% | $11.8B | $8.16 | 6.2 |
| italics below = DCF projection · 10yr Rev CAGR: 3.6% |
| 2027.Q1 | $8.3B | +-0.0% | 28.0% | 15.8% | $1.9B | $0MM | $1.9B | 7.6% | $1.8B | 16.6% | $11.8B | $10.47 | 7.6 |
| 2028.Q1 | $8.6B | +3.6% | 26.1% | 16.3% | $1.9B | −$57MM | $1.8B | 7.7% | $1.6B | 15.8% | $11.8B | $10.05 | 7.9 |
| 2029.Q1 | $8.9B | +3.8% | 21.2% | 16.7% | $1.6B | −$108MM | $1.5B | 7.8% | $1.2B | 13.2% | $11.9B | $8.42 | 9.4 |
| 2030.Q1 | $9.2B | +3.8% | 33.8% | 17.2% | $2.6B | −$1.8B | $750MM | 7.9% | $556MM | 20.1% | $13.8B | $13.86 | 5.7 |
| 2031.Q1 | $9.7B | +5.1% | 33.8% | 17.7% | $2.7B | −$2.0B | $658MM | 8.0% | $451MM | 18.2% | $15.8B | $14.48 | 5.5 |
|
| Term. Yr+ | $12.3B | 4.1% | 22.9% | 20.0% | $2.2B | −$938MM | $1.3B | 8.6% | $13.4B | 9.8% | — | — | — |
Active scenario IV: $115 (+45.1% vs market)